Berkeley Facilities

 

United States Manufacturing Capacity

With state-of-the-art clinical and commercial manufacturing facilities across the United States, Europe and Asia, AGC Biologics has the capacity and flexibility to meet each customer’s individual manufacturing needs. Our manufacturing facilities are multi-process, engineered for unidirectional flow and segregated to produce multiple products at different stages of manufacturing in multiple parts of the facility. This increases the flexibility and number of manufacturing solutions available to meet clients’ rigorous manufacturing and quality needs. Right. On Time.

  • Berkeley Facility
  • Berkeley Facility
  • Berkeley Facility
  • Berkeley Facility

BERKELEY FACILITy

AGC Biologics currently operates two cGMP manufacturing lines for clinical production in our Berkeley, California facility. This additional capacity in the U.S. allows for technological flexibility to our customers – Right. On Time.  Whatever the challenge, AGC Biologics is your solution for clinical and commercial manufacturing.

 

Facility Equipment and Technology

TWO MAMMALIAN CELL CULTURE PRODUCTION SUITES AND DOWNSTREAM SUITE

  • Suite 1
    • 3000L stainless steel production bioreactor
    • 500L stainless steel production bioreactor
    • Dedicated cell expansion suit
  • Suite 2
    • 2000L single-use production bioreactor
    • 500L single use production bioreactor
    • 100L single-use production bioreactor
    • Dedicated cell expansion suite
  • Downstream Suite
    • Chromatography columns up to 80 cm diameter
    • Pre and post viral segregation
    • Final formulation and fill

 

cGMP CELL BANKING AND STORAGE

  • Mammalian master and working cell banks
  • Up to 400 vials
  • Production and storage